16.200
−1,82%
2026-10-19
Fundamental Analysis
70 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +21.9% | +108.7% | 3 / 3 | +41.8% | +0.21 pp | +0.26 pp | +25.9% | 3.44 | 4.62 | 2.675 | +41,8% | 49,0 | +65,1% | 4.62 | 5.79 | −20,2% |
| Pts | 4 | 12 | 12 | 12 | 8 | 8 | 12 | -4 | 12 | |||||||
Valuation annotation:Price: 16.200 (close price on 2026-10-19)EPS (TTM): 3.506
Financial charts
1.Revenue & growth
VND bn2.647Q2/26
1.Revenue & growth
VND bn2.647Q2/26
2.Profit & growth
VND bn49,0Q2/26
3.Profit mix (Penman)
VND bn243Q2/26
4.Margins & cost structure
%5.4%Q2/26
5.Returns & cash cycle
% · days10.8%Q2/26
6.Earnings quality & cash
VND bn-403Q2/26
7.Asset structure
VND bn5.583Q2/26
8.Funding & debt health
VND bn · times5.583Q2/26
9.Revenue backlog
VND bn44,9Q2/26
10.Valuation
times · %5,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %907Q2/26
Adjusted EPS growth, latest quarter
58.3%
Average adjusted EPS growth, 3 quarters
121%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
4.2%
Source: vnstockData through Q2/26